69
Immunotech Biopharm Ltd
6978.HK · HKSE
$0.40 +0.00% (+$0.00)
1M +5.33%
Market Cap ¥208.7M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.22
44.3% downside
Current Price
$0.4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6978.HK is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 40.02%
Asset turnover 0.00x
ROA 37.27%
Debt
0 /100
High Current ratio 0.35x
Int. coverage -25.54x
Debt/Equity N/A
Stability
28 /100
Unstable Beta 0.12x
Profitable years 0
EPS volatility 31.49%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6978.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jian Zhang
Employees
189
Headquarters
Beijing
Upcoming events
19 MAR
Earnings
Upcoming earnings report